简要行为疗法与安非他酮治疗克罗恩病年轻成人睡眠与疲劳:一项探索性开放试验研究
该研究为两阶段开放试验,评估阶梯式干预对克罗恩病青少年和年轻成人睡眠质量差及疲劳的可行性与效果。第一阶段52例接受4周炎症性肠病简要睡眠行为疗法(BBTS-I),睡眠质量和疲劳均显著改善(p < .001)。第二阶段33例接受BBTS-I联合安非他酮缓释片(BUP-SR)而19例仅继续BBTS-I,8周后两组睡眠、疲劳、焦虑和抑郁症状均进一步显著改善,但两组间无显著差异。
要点
- BBTS-I治疗4周后克罗恩病患者睡眠质量和疲劳均显著改善(p < .001)。
- 第二阶段两组睡眠、疲劳、焦虑和抑郁症状均进一步显著改善,但组间无显著差异。
- 阶梯式干预可改善克罗恩病患者睡眠障碍,但疲劳仅部分改善。
核心结论
- 阶梯式干预方法显示,BBTS-I可改善克罗恩病患者的睡眠障碍,但疲劳仅部分改善。
- 对于选择在行为疗法基础上加用BUP-SR的部分患者,疲劳进一步改善,但与单用行为疗法相比未达统计学显著效果。
研究设计与样本
- 本研究为两阶段开放试验,探索针对睡眠和疲劳的干预措施。
- 在包括定量测量和评估睡眠及身心健康的访谈的初始综合评估后,12周干预包括两个连续步骤:第一步为4周炎症性肠病简要睡眠行为疗法(BBTS-I),第二步为对继续存在疲劳的受试者亚组加用精神药物安非他酮缓释片(BUP-SR)8周。
- 18个月内共接触232例克罗恩病患者(中位年龄=24,中位性别=女性),其中112例在匹兹堡睡眠质量指数(PSQI)和多维疲劳量表(MFI)筛查阳性,68例完成更全面的基线评估。
- 68例患者中52例参与第一阶段BBTS-I干预;52例中33例参与BUP-SR+BBTS-I组,19例参与仅BBTS-I干预组。
主要发现
- BBTS-I治疗4周后,睡眠质量(p < .001)和疲劳(p < .001)均显著改善。
- 第二阶段8周后,两个干预组的睡眠、疲劳、焦虑和抑郁症状均进一步显著改善,但两组间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Sleep disturbances and fatigue are common symptoms amongst patients with Crohn's disease (CD). The aim of this study was to test the feasibility and effects of a pragmatic, stepped-care intervention for the treatment of poor sleep quality and fatigue in adolescents and young adults with CD. METHODS: This study is a two-phase open trial exploring interventions for sleep and fatigue. After the initial comprehensive assessment which included quantitative measures and an interview to evaluate sleep and physical and mental health, the 12-week intervention consisted of two sequential steps: 1) a brief behavioral therapy for sleep in inflammatory bowel disease (IBD) (BBTS-I; 4 weeks) and 2) adding the psychotropic medication, bupropion sustained release (BUP-SR; 8 weeks), for the subset of subjects continuing to experience fatigue. RESULTS: 232 CD patients (median age=24, median sex=female) were approached over 18 months, of whom 112 screened positive on the Pittsburgh Sleep Quality Index (PSQI) and multi-dimensional fatigue inventory (MFI), with 68 CD patients completing the more comprehensive baseline assessment. Of the 68 patients, 52 participated in Phase I of the BBTS-I intervention. Following 4-weeks of the BBTS-I, there were significant improvements in sleep quality (p < .001) and fatigue (p < .001). As part of Phase II, of the 52 patients who met fatigue threshold criteria, 33 patients participated in the BUP-SR+BBTS-I arm while 19 participated in the BBTS-I only intervention group. After 8 weeks of Phase II, both intervention groups saw significant further improvement in sleep, fatigue, anxiety and depressive symptoms, but without significant differences between the two intervention groups. CONCLUSIONS: A stepped-care approach shows that we can improve sleep disturbance with BBTS-I in CD patients, but fatigue only partially improves. For a subset of patients who chose to add BUP-SR to their behavioral therapy, fatigue improves further but not to a statistically significant effect compared to behavioral therapy alone.
引用
- Hashash JG, Knisely MR, Germain A, et al. Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn's Disease: An Exploratory Open Trial Study. Clin Gastroenterol Hepatol. 2020. PMID: 33010410. doi:10.1016/j.cgh.2020.09.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。